Exagen Inc Capital Reinvestment Ratio

Latest as of June 2026: 0.14x

Exagen Inc capital reinvestment ratio. Exagen Inc (XGN) has a Capital Reinvestment Ratio of 0.14x as of June 2026, meaning it reinvests 0% of its operating cash flow ($3.99 Million) in capital expenditures ($543.00K). See Exagen Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.14x

Capex / Operating Cash Flow

Operating Cash Flow

$3.99 Million

USD

Capital Expenditures

$543.00K

USD

Data as of

Jun 2026

Most recent filing

Exagen Inc Capital Reinvestment Ratio by Year (None–None)

Exagen Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see XGN cash flow metrics.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow